New National Health and Medical Research Council guidelines at odds with public hospital bans in Queensland and NT
Get our breaking news email, free app or daily news podcast
Australia’s largest medical research organisation has advised puberty blockers are appropriate for the gender-affirming care of young people in certain circumstances, following a year-long review of international evidence.
The federal government last year commissioned the commonwealth-funded National Health and Medical Research Council (NHMRC) to develop the advice in response to bans in Queensland and the Northern Territory public hospitals imposed by their governments.
The New Zealand government later followed suit despite widespread opposition in the health sector and warnings that the bans would harm children.
The council’s interim national clinical practice guidelines released on Monday, which advise conditional use of puberty suppressants for children, could put pressure on state and territory governments to consider their positions.
The council explicitly rejected alternative approaches to gender-affirming care proposed by opponents of the approach – such as the “wait and see” model - as a form of withholding care for children which it stated “can affect the young person’s physical and mental health, wellbeing, and ability to function”.
Puberty blockers are a class of drugs used to stop the body producing oestrogen and testosterone.
